SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 44.70 |
| Enterprise Value ($M) | 44.46 |
| Book Value ($M) | 16.92 |
| Book Value / Share | 1.27 |
| Price / Book | 2.64 |
| NCAV ($M) | -47.52 |
| NCAV / Share | -3.56 |
| Price / NCAV | -0.94 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.97 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -0.83 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.78 |
| Current Ratio | 0.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.54 |
| Assets | 70.97 |
| Liabilities | 54.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.50 |
| Operating Income | -22.86 |
| Net Income | -27.78 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -23.32 |
| Cash from Investing | -0.93 |
| Cash from Financing | 12.19 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Bio-rad Laboratories, Inc. | 8.99 | ||
| 13D/A | Broadwood Partners, L.p. | 37.60 | -91.11 | |
| 13G/A | Pura Vida Investments, Llc | 8.45 | -95.74 | |
| 13G/A | AWM Investment Company, Inc. | 9.10 | -89.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 5,141 | 27,495 | 18.70 | |
| 6,092 | 21,290 | 28.61 | |
| 1,589 | 7,874 | 20.18 | |
| 1,975 | 18,316 | 10.78 | |
| 474 | 8,313 | 5.70 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OCEA – Ocean Biomedical, Inc. | OCGN – Ocugen, Inc. |
| OCUP – Ocuphire Pharma, Inc. | OKYO – OKYO Pharma Limited |
| ONCO – Onconetix, Inc. |
Financial data and stock pages provided by
Fintel.io